737 filings
Page 28 of 37
CORRESP
hqntq
23 Mar 09
Correspondence with SEC
12:00am
8-K
kshoyglp8vabnxxkq
20 Mar 09
Cost Associated with Exit or Disposal Activities
12:00am
CORRESP
du5s8v4f
13 Mar 09
Correspondence with SEC
12:00am
CORRESP
exfz 7cor75ok0
6 Mar 09
Correspondence with SEC
12:00am
CORRESP
gb7ot
13 Feb 09
Correspondence with SEC
12:00am
8-K
rzq43wr wq
10 Feb 09
Adventrx Provides Update on Strategic Transaction Process
12:00am
8-K
z2va9s
5 Feb 09
Departure of Directors or Certain Officers
12:00am
8-K
5n5zecc m4vqb849l4y4
2 Feb 09
Departure of Directors or Certain Officers
12:00am
CORRESP
rrybul1v7
15 Jan 09
Correspondence with SEC
12:00am
8-K
sbmixscuoy5vgsntbw
8 Jan 09
Departure of Directors or Principal Officers
12:00am
8-K
8rvh9d44f1mh0 spy
5 Jan 09
Adventrx Announces Further Cost-cutting Measures
12:00am
8-K
00j36xh0fhv6
2 Jan 09
Departure of Directors or Principal Officers
12:00am
8-K
evel5r63o3kcwhpl5
23 Dec 08
Departure of Directors or Principal Officers
12:00am
8-K
4ibywmzfrwk0s
15 Dec 08
Departure of Directors or Principal Officers
12:00am
8-K
7n77fxaukptwno
15 Dec 08
Adventrx Exploring Strategic Options
12:00am
CORRESP
fs751o
12 Nov 08
Correspondence with SEC
12:00am
8-K
ep4t8p bdfo8b
7 Nov 08
Departure of Directors or Principal Officers
12:00am
8-K
a36wfo1w2vfaed45zmh
6 Nov 08
Adventrx Pharmaceuticals Reports Third Quarter 2008 Financial Results and Business Update
12:00am
UPLOAD
i2ty47rz74lffsg
3 Nov 08
Letter from SEC
12:00am